June 16, 2015

Key Drug Interactions

Key Drug Interactions
·         Serotonin syndrome
o   Mental status changes, agitation, diaphoresis, tachycardia, death
o   monoamine oxidase inhibitor (MAOI) - phenelzine or tranylcypromine sulfate
o   dextromethorphan, meperidine, and SSRI such as fluoxetine
o   stop fluoxetine 5 weeks before MAOI due to long half-life of metabolite norfluoxetine
o   wait 2 after MAOI ends and SSRI begins 
·         Digoxin and Quinidine
o   Increase in digoxin levels
o   Quinidine displaces digoxin from binding sites and leading to a decreased Vd of digoxin
o   Quinidine decreases renal and nonrenal excretion of digoxin
·         Sildenafil and Isosorbide mononitrate
o   Hypotension due to sildenafil being a PDE5 inhibitor and nitrates increase cGMP
·         Potassium (chloride, bicarbonate, citrate, acetate, gluconite, and iodide) and potassium sparing diuretics (spironolactone, amiloride, triamterene)
o   Leads to hyperkalemia, cardiac failure, and death especially in patients in renal impairment
·         Clonidine and Propanolol
o   Rebound hypertension when suddenly stopping clonidine
o   Clonidine is a central alpha-2 adrenergic agonist that causes a decrease in NE
o   Alpha-1 receptors then become sensitized because of less norepinephrine
o   With suddenly withdrawn a large increase in norepinephrine occurs leading to vasoconstriction by the sensitized alpha1 receptors
o   Body cannot compensate because the beta-2 receptors are blocked
·         Warfarin and NSAID (diflunisal, ketoprofen, piroxicam, sulindac, diclo-fenac, and ketorolac)
o   increase the risk of GI bleeding
o   acetaminophen or nonacetylated salicylates (magnesium salicylate or salsalate) is an alternative
·         Theophylline and Ciprofloxacin
o   Increase in theophylline levels
o   Theophylline is metabolized by CYP1A2
o   Ciprofloxacin, clarithromycin, erythromycin, fluvoxamine, and cimetidine inhibit CYP1A2
o   levofloxacin or ofloxacin is an alternative
·         Pimozide and Ketoconazole
o   Prolong QT interval and ventricular arrhythmias (torsades de pointes)
o   Pimozide is metabolized by CYP3A4
o   Ketoconazole, fluconazole inhibit CYP3A4
o   Terbinafine is safer
·         Methotrexate and Probenecid or Penicillins or Salicylates
o   Increase methotrexate levels
o   Probenecid inhibits renal secretion
o   methotrexate toxicity include diarrhea, vomiting, diaphoresis, renal failure, and death
o   alternatives include acetaminophen not salicylates or NSAIDS (celecoxib okay, rofexcoxib NOT okay)
·         Bromocriptine and Pseudoephedrine
o   peripheral vasoconstriction, ventricular tachycardia, seizures, and possibly death
o   Bromocriptine dopamine agonist for Parkinson’s (first line therapy is bromocriptine or other dopamine agonist such as ropinirole, pramipexole, or pergolide
o   Avoid all sympathomimetics with bromocriptine

Source: http://www.pharmacytimes.com/publications/issue/2002/2002-11/2002-11-7010